FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Compounding LET Gel 4% Recall

LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0

US Compounding Inc · Conway, AR

Risk level
Class II
Reported by FDA
Feb 20, 2019
Recall ID
D-0482-2019
Check your lot numberHow we source this data

Summary

US Compounding recalled LET Gel 4% starting Jan 24, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0482-2019 on Feb 20, 2019. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

Product description

LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.

Lot numbers, UPCs & expiration codes

Labeled as Lot# YYYDDYY@XX, Beyond Use Date: MM/DD/YYYY.

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0482-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 24, 2019
FDA report date
Feb 20, 2019
Quantity
1931 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
US Compounding Inc

Original FDA data

Every field from FDA enforcement report D-0482-2019, exactly as published.

Show all FDA fields
City
Conway
State
AR
Status
Terminated
Country
United States
Event ID
81982
Address
1270 Dons Ln
Code information
Labeled as Lot# YYYDDYY@XX, Beyond Use Date: MM/DD/YYYY.
Postal code
72032-4753
Report date
Feb 20, 2019
Product type
Drugs
Recall number
D-0482-2019
Classification
Class II
Recalling firm
US Compounding Inc
Product quantity
1931 syringes
Termination date
Jan 24, 2020
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.
Voluntary / mandated
Voluntary: Firm initiated
Product description
LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jan 24, 2019
Initial firm notification
Letter
Center classification date
Feb 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0482-2019, published Feb 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls